[{"address1": "201 Brookline Avenue", "address2": "Suite 901", "city": "Boston", "state": "MA", "zip": "02215", "country": "United States", "phone": "857 320 4900", "website": "https://www.tangotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 155, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barbara L. Weber M.D.", "age": 67, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 1039811, "exercisedValue": 0, "unexercisedValue": 9991192}, {"maxAge": 1, "name": "Dr. Adam S. Crystal M.D., Ph.D.", "age": 47, "title": "President of Research & Development", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 977216, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Ashworth FRS, Ph.D.", "age": 62, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William G. Kaelin Jr., M.D.", "age": 66, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Antoni  Ribas M.D., Ph.D.", "age": 56, "title": "Founder & Member of Scientific Advisory Board", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy  Redfern", "age": 45, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Palmieri Ph.D.", "title": "Head of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jannik N. Andersen Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas J. Barry Esq., J.D.", "age": 54, "title": "Chief Legal Officer, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie  Carretero", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.86, "open": 1.88, "dayLow": 1.835, "dayHigh": 1.995, "regularMarketPreviousClose": 1.86, "regularMarketOpen": 1.88, "regularMarketDayLow": 1.835, "regularMarketDayHigh": 1.995, "payoutRatio": 0.0, "beta": 0.873, "forwardPE": -1.3732395, "volume": 819696, "regularMarketVolume": 819696, "averageVolume": 902325, "averageVolume10days": 864550, "averageDailyVolume10Day": 864550, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 210810608, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 12.015, "priceToSalesTrailing12Months": 5.011068, "fiftyDayAverage": 2.6417, "twoHundredDayAverage": 6.1134, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -10613614, "profitMargins": 0.0, "floatShares": 46645311, "sharesOutstanding": 108108000, "sharesShort": 7036859, "sharesShortPriorMonth": 5441461, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0651, "heldPercentInsiders": 0.08402, "heldPercentInstitutions": 0.99509, "shortRatio": 10.69, "shortPercentOfFloat": 0.1193, "impliedSharesOutstanding": 108108000, "bookValue": 1.852, "priceToBook": 1.0529158, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -130302000, "trailingEps": -1.19, "forwardEps": -1.42, "enterpriseToRevenue": -0.252, "enterpriseToEbitda": 0.074, "52WeekChange": -0.76758045, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 1.95, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.5, "targetMedianPrice": 11.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 257916992, "totalCashPerShare": 2.386, "ebitda": -143096000, "totalDebt": 36493000, "quickRatio": 6.757, "currentRatio": 6.978, "totalRevenue": 42069000, "debtToEquity": 18.291, "revenuePerShare": 0.385, "returnOnAssets": -0.2531, "returnOnEquity": -0.57576, "grossProfits": -101849000, "freeCashflow": -67267872, "operatingCashflow": -131501000, "revenueGrowth": -0.242, "grossMargins": -2.421, "ebitdaMargins": 0.0, "operatingMargins": -9.93685, "financialCurrency": "USD", "symbol": "TNGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Tango Therapeutics, Inc.", "regularMarketChangePercent": 4.8387113, "regularMarketPrice": 1.95, "shortName": "Tango Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1741993753, "regularMarketTime": 1741982400, "exchange": "NGM", "messageBoardId": "finmb_424111353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1599139800000, "postMarketChangePercent": -1.53847, "postMarketPrice": 1.92, "postMarketChange": -0.0300001, "regularMarketChange": 0.09000003, "regularMarketDayRange": "1.835 - 1.995", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 902325, "fiftyTwoWeekLowChange": 0.23000002, "fiftyTwoWeekLowChangePercent": 0.13372093, "fiftyTwoWeekRange": "1.72 - 12.015", "fiftyTwoWeekHighChange": -10.065001, "fiftyTwoWeekHighChangePercent": -0.8377029, "fiftyTwoWeekChangePercent": -76.75804, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746534600, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.42, "epsCurrentYear": -1.30238, "priceEpsCurrentYear": -1.4972589, "fiftyDayAverageChange": -0.6917, "fiftyDayAverageChangePercent": -0.26183894, "twoHundredDayAverageChange": -4.1633997, "twoHundredDayAverageChangePercent": -0.6810285, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Tango Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]